Correlation Between Eli Lilly and CEL SCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and CEL SCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and CEL SCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and CEL SCI Corp, you can compare the effects of market volatilities on Eli Lilly and CEL SCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of CEL SCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and CEL SCI.

Diversification Opportunities for Eli Lilly and CEL SCI

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Eli and CEL is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and CEL SCI Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CEL SCI Corp and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with CEL SCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CEL SCI Corp has no effect on the direction of Eli Lilly i.e., Eli Lilly and CEL SCI go up and down completely randomly.

Pair Corralation between Eli Lilly and CEL SCI

Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.31 times more return on investment than CEL SCI. However, Eli Lilly and is 3.2 times less risky than CEL SCI. It trades about 0.09 of its potential returns per unit of risk. CEL SCI Corp is currently generating about -0.01 per unit of risk. If you would invest  35,931  in Eli Lilly and on September 18, 2024 and sell it today you would earn a total of  41,969  from holding Eli Lilly and or generate 116.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  CEL SCI Corp

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
CEL SCI Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CEL SCI Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eli Lilly and CEL SCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and CEL SCI

The main advantage of trading using opposite Eli Lilly and CEL SCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, CEL SCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will offset losses from the drop in CEL SCI's long position.
The idea behind Eli Lilly and and CEL SCI Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital